Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Kansas Medical Center
This study will use a double-blind, randomized, cross-over design with subjects serving as their own controls. This study will be conducted over a consecutive five-week period.
All subjects will be asked to discontinue taking their short- and long-acting beta-agonist medication 12 and 24 hours respectively prior to data collection. Also, all subjects will be asked to refrain from caffeine, physical activity, and NSAID use 24 hours prior to testing. In addition all subjects will be asked to abstain from taking any vitamin supplement during the course of the study.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Student or student-athlete who has tested positive for EIB
Able to communicate in English
You may not be if
Forced expiratory volume in 1 second (FEV1) \< 70% of predicted, cardiac history,